Search Results 151-160 of 18112 for CLL

  1. Skin Biopsy Clinical Trials - Mayo Clinic Research

    ... Chronic Lymphocytic Leukemia Rochester, MN. The purpose of this study is to ... CLL as well as non-CLL patients. Study to Validate Methods Assessment of ...

  2. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  3. A Study to Evaluate the Safety and Effectiveness of JBH492 in Patients with Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma - Mayo Clinic

    Confirmed diagnosis of chronic lymphocytic leukemia (CLL). · Must have received at least two (2) prior therapy regimens. · Patients with Richter's transformation ...

  4. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  5. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. A Study to Evaluate Olaparib and Temozolomide in ...

  6. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  7. A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    Diagnosis of chronic lymphocytic leukemia (CLL) per diagnostic criteria and relapsed or refractory CLL per the iwCLL guidelines. Previously treated with 1-3 ...

  8. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. A Study of Nab-Paclitaxel as Maintenance ...

  9. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  10. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. A Study of Nab-Paclitaxel as Maintenance ...